301 Dashboard
302 Dashboard
Announcements 301
Announcements 302
Material Requests
PRR Services
Site Support
FAQs
VANQUISH-2 Viking Rowing for Retention Challenge End of July Update. Reminder to continue to submit retention tips for additional points!
VANQUISH-2 Viking Rowing for Retention Challenge First Update. Includes helpful retention tips for your reference.
Advarra System Updates. Vanquish 3. Discontinuation of Study Treatment in IRT. Post Auto-Injector Survey. PEth Testing. Subject eDiary. Site Communication Reminder.
PI/Medical Monitoring Drop-In Sessions. Advarra System Updates. Vanquish 3. Discontinuation of Study Treatment in IRT. Post Auto-Injector Survey.
Spanish Speaking Subject Reminders: Please be advised for Spanish speaking participants, the Vanquish studies have documents available in US and PR Spanish.
Site Investigational Product Subject Accountability Log | Part A | Update to include total volume administered.
PI/Medical Monitoring Discussion - Malnutrition Reporting. Study Procedure Reminder. Lab Processing Reminder. MRL Quick Reference Guide V8.0.
Review Concomitant Medication During Re-Consent. Autoinjectors. Update ePRO App. Malnutrition Assessment Updates. PI Drop-In Session Q&A Log. Updated eCRF Completion Guidelines. Site Hub Log In.
IP Expiry Memo Follow Up. Protocol Amendment V5.0 Materials. Vitamin Deficiency Reporting. MRL Malnourishment Assessments.
IP Expiry Memo Follow Up. PI Medical Monitoring Drop-In Q&A Log. Protocol Amendment V5.0 Materials. Vitamin Deficiency Reporting.
Protocol Clarification Letter #5. Study Protocol Clarification & Administrative Letters. IP Expiry Extension Memo. Updated Medpace Study Team List. MRL Assessment Testing Follow-Up
Medical Monitoring Drop-in Sessions. VK2735-302 IRT Updates. Updated Study Supply Request Form. MRL Malnourishment Assessment. EDC Updates. Site Hub Portal. Clarification on Data Entry Rollover.
Clarification on Malnutrition Collection and Supply Details. Clarification on Data Entry Rollover.
The study has officially closed for screening and randomization. All subjects remaining in screening will be required to screen fail.
Randomization remains open for VANQUISH-2. We recommend scheduling randomization visits promptly when eligibility is confirmed.
Enrollment Update: Randomization remains open for VANQUISH-2. Study Reminder for Daylight Savings: Ensure consideration is taken for the upcoming time change.
Screening is now closed for VANQUISH-2. Additionally, approximately 50 randomization slots remain. Once these slots have been filled, randomization will be closed.
At the time of this notification, there are approximately 0 screening slots available before screening will close. We expect this to happen at the end of day today or early tomorrow and will notify you once it has formally closed.
PI/CRC Call Follow-up. Autoinjector Injection Video. Study Reminders about the Pharmacy Manual and Advarra ICF Changes.
We are excited to see the recent activity on screening and randomizations. There are approximately 75 screening slots remaining for VANUISH-2, which we expect to be filled in the next week.
Auto Injector Roll Out & Supply Details. Drug Holiday and Restarting IP. MRL Reminders. Investigator's Brochure. Upcoming PI/CRC Teleconferences (PAV5.0 Training and Important Study Updates).
There are approximately 100 screening slots remaining for VANQUISH-2. There has been an increase in screenings and randomizations last week and we want to ensure awareness that screening will close once these slots are filled.
Enrollment Updates. Initial Auto Injector & Supply Shipments. BMI Dose Modification Under PA5. MRL Reminders. Upcoming PI/CRC Teleconferences (PAV5.0 Training and Important Study Updates).
Upcoming PICRC Teleconferences (PAV5.0 raining and Important Study Updates). Enrollment Update. IP Storage. Visit Windows.
Upcoming PI/CRC Teleconferences (PAV5.0 Training). Enrollment Update. IP Storage Concerns Survey. Visit Guidance. Concomitant Medication. IP Dose Modification. PCS Travel and Reimbursement Policy V3.
Enrollment Update. IP Storage Concerns Survey. IRT Reminder for Resuming IP After 2 Consecutive Missed Doses. ECG Acquisition and Submission Manual V5.0.
VANQUISH 302 Protocol Amendment 4.0 Materials. Laboratory Manual v4.0, dated 19-Dec-2025. Study Update Recruitment: Nearing the Final Goal for Recruitment.
VANQUISH 301/302 Dose Dispensing Worksheet. Temperature Excursion Reporting Reminders. Update on Hypoglycemia Symptoms Diary and SMBG Data Reports. MRL Reminder. Autoinjector.
Enrollment Open. Sharps Container and Coolers Shipments. End of Study Stipend Clarification.
July 31, 2026
.png)
